Aenova Expands Automated Semi-Solids Tube Packaging Capacity at Feldkirchen Site

New state-of-the-art high-speed line boosts annual capacity to over 50 million tubes per year and enhances flexibility for pharmaceutical creams, gels and ointments.

Aenova invests in new high-speed, fully automated tube packaging line

Aenova has expanded its manufacturing and packaging capabilities for semi-solid pharmaceutical products at its site in Feldkirchen, Germany. The site has installed a new fully automated, state-of-the-art high-speed tube packaging line for pharmaceutical creams, gels and ointments.

With this investment, Feldkirchen increases its annual tube filling and packaging capacity to a minimum of 50 million tubes. This strengthens Aenova’s position as a contract development and manufacturing organization (CDMO) for topical pharmaceutical dosage forms and supports customers in bringing their products to market reliably and efficiently.

“With this new high-speed, fully automated tube packaging line, we significantly strengthen Feldkirchen as a center of excellence for topical pharmaceuticals within the Aenova Group,” says Andreas Wenzel, Managing Director Aenova Feldkirchen. “The additional capacity and flexibility in tube formats, combined with full serialization and aggregation, enable us to support our customers even better in securing reliable, high-quality supply for patients worldwide.”

Advanced serialization and aggregation for global supply

The new line is designed to meet current and future regulatory and quality requirements in international markets. Key features include:

• Full serialization capability for compliant supply to regulated markets
• Bollini stickering option to flexibly meet specific country requirements
• Bundle serialization for efficient handling and tracking
• Aggregation up to pallet level for end-to-end traceability and optimized logistics

These capabilities support customers in fulfilling global track & trace regulations and in strengthening product safety and supply chain security.

High flexibility for multiple tube formats

The line can handle a broad range of tube formats and materials, allowing efficient production for diverse product portfolios. It can process:

• Different tube sizes to cover various markets and indications
• Plastic and aluminum tubes, enabling tailored solutions depending on product stability and customer preferences

This flexibility means that both existing and new customers can consolidate multiple products and presentations on a single, highly efficient line.

Supporting growing demand for topical pharmaceuticals

Demand for topical pharmaceutical products such as creams, gels and ointments continues to grow, driven by the increasing prevalence of dermatological and pain conditions and the associated rise in both prescription and OTC products. This trend is further supported by patient-friendly dosage forms that are easy to apply and enable targeted local therapy. In addition, there is an increased focus on supply reliability and high-quality packaging, particularly in highly regulated markets, which further reinforces the demand for robust topical product solutions.

By expanding its automated tube packaging capacity at Feldkirchen, Aenova serves these trends with scalable capacity, high-quality packaging and an infrastructure that is ready for current and future track & trace regulations.

Strengthening Aenova’s global network

The investment at Feldkirchen is part of Aenova’s broader strategy to expand efficient, highly automated production and packaging capacities across its global network. With this new line, the Feldkirchen site becomes an even stronger hub for topical pharmaceuticals, offering:

• End-to-end services from bulk production to final packaged product
• Compliance with international GMP and serialization standards
• High flexibility for tech transfers and product launches

The new high-speed tube packaging line at Aenova Feldkirchen combines increased capacity, advanced automation and high flexibility in tube formats with full serialization and aggregation capabilities. This enables Aenova to better support pharmaceutical customers in bringing creams, gels and ointments safely, efficiently and reliably to patients around the world.

Looking for an experienced, reliable drug development or manufacturing partner for your Semi-Solids project?

Contact us today to learn more about our capabilities and how we can best support your needs.

Contact Us